D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Toronto Dominion Bank
TD
$200B
| $102M | 0.09% |
1,688,763
+1,667,887
| +7,989% | +$101M |
|
252
CALL
AbbVie
ABBV
$466B
| $102M | 0.09% |
559,900
-619,900
| -53% | -$107M |
|
253
PUT
Qualcomm
QCOM
$190B
| $101M | 0.09% |
594,000
-395,400
| -40% | -$61.1M |
|
254
Fair Isaac
FICO
$20.5B
| $99.1M | 0.08% |
79,332
-158,707
| -67% | -$199M |
|
|
255
CALL
Mastercard
MA
$495B
| $99M | 0.08% |
205,600
-165,700
| -45% | -$75.7M |
|
256
PUT
Moderna
MRNA
$61.5B
| $98.9M | 0.08% |
928,300
+230,900
| +33% | +$23.3M |
|
257
Nike
NKE
$52.7B
| $98.9M | 0.08% |
1,052,368
+786,860
| +296% | +$80M |
|
258
PUT
DraftKings
DKNG
$10.8B
| $98.5M | 0.08% |
2,169,500
-1,048,700
| -33% | -$42.7M |
|
259
PUT
Morgan Stanley
MS
$318B
| $98.5M | 0.08% |
1,045,600
-2,300
| -0.2% | -$203K |
|
260
CALL
Pinduoduo
PDD
$112B
| $97.8M | 0.08% |
841,300
-924,100
| -52% | -$121M |
|
261
PUT
Lam Research
LRCX
$361B
| $97.7M | 0.08% |
1,006,000
+139,000
| +16% | +$12.2M |
|
262
Intercontinental Exchange
ICE
$87.3B
| $97.3M | 0.08% |
708,106
+474,083
| +203% | +$63M |
|
263
Consolidated Edison
ED
$39B
| $97.2M | 0.08% |
1,069,826
+244,550
| +30% | +$21.9M |
|
264
PUT
Affirm
AFRM
$24B
| $97.1M | 0.08% |
2,605,900
+1,255,400
| +93% | +$50.1M |
|
265
STMicroelectronics
STM
$44.8B
| $97M | 0.08% |
2,243,224
+2,039,782
| +1,003% | +$92M |
|
266
Boston Scientific
BSX
$62.8B
| $95.8M | 0.08% |
1,398,793
+879,341
| +169% | +$56.5M |
|
267
Clorox
CLX
$10B
| $95.6M | 0.08% |
624,175
+47,789
| +8% | +$7.13M |
|
268
Fortinet
FTNT
$125B
| $95.5M | 0.08% |
1,398,104
-1,625,911
| -54% | -$108M |
|
269
Freeport-McMoran
FCX
$103B
| $95.4M | 0.08% |
2,028,175
+1,076,374
| +113% | +$43.5M |
|
270
Duolingo
DUOL
$6.64B
| $93.8M | 0.08% |
425,261
-543,762
| -56% | -$111M |
|
|
MRO
271
DELISTED
Marathon Oil Corporation
MRO
| $93.5M | 0.08% |
3,300,428
+1,142,920
| +53% | +$27.6M |
|
272
Welltower
WELL
$165B
| $93.1M | 0.08% |
996,515
+416,369
| +72% | +$37.7M |
|
273
CALL
American Express
AXP
$210B
| $92.6M | 0.08% |
406,700
+214,300
| +111% | +$44.4M |
|
274
CALL
First Solar
FSLR
$21.1B
| $91.8M | 0.08% |
543,700
+34,200
| +7% | +$5.26M |
|
275
Nutrien
NTR
$36.8B
| $91.7M | 0.08% |
1,688,221
+690,390
| +69% | +$36M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.